https://orcid.org/0000-0001-8770-1042
Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Peter J. Hotez, Rakesh Adhikari, Wen-Hsiang Chen, Yi-Lin Chen, Portia Gillespie, Nelufa Y. Islam, Brian Keegan, Rakhi Tyagi Kundu, Jungsoon Lee, Zhuyun Liu, Jason T. Kimata, Numan Oezguen, Jeroen Pollet, Cristina Poveda, Kay Razavi, Shannon E. Ronca, Ulrich Strych, Syamala R. Thimmiraju, Leroy Versteeg, Maria Jose Villar-Mondragon, Junfei Wei, Bin Zhan & Maria Elena Bottazzi. (2023) From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access. Expert Review of Vaccines 22:1, pages 495-500.
Read now
Read now
Lucas J. Gutiérrez, Rodrigo D. Tosso, M. Natalia C. Zarycz, Ricardo D. Enriz & Héctor A. Baldoni. (2022) Epitopes mapped onto SARS-CoV-2 receptor-binding motif by five distinct human neutralising antibodies. Molecular Simulation 48:18, pages 1616-1626.
Read now
Read now
Samayaditya Singh & Insaf Ahmed Qureshi. (2022) Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics 40:7, pages 2917-2933.
Read now
Read now
Sait Berk Barlas, Nur Adalier, Omer Dasdag & Suleyman Dasdag. (2021) Evaluation of SARS-CoV-2 with a biophysical perspective. Biotechnology & Biotechnological Equipment 35:1, pages 392-406.
Read now
Read now
Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, Aasim Habib Wani, Abrar Ul Haq, Archana Saxena, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Yashpal Singh Malik, Ranjit Sah, Ali A. Rabaan, Alfonso J. Rodriguez Morales & Kuldeep Dhama. (2020) COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Human Vaccines & Immunotherapeutics 16:12, pages 2891-2904.
Read now
Read now
Leonard Moise, Ted M. Ross, Daniel F. Hoft, William D. Martin & Anne S. De Groot. (2020) Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Review of Vaccines 19:9, pages 781-784.
Read now
Read now
Articles from other publishers (85)
Lu Fan, Li Wang, Xiaoju Wang & Hongbo Zhang. (2023) Exosomes-based particles as inhalable COVID-19 vaccines. Biomedical Technology 4, pages 24-27.
Crossref
Crossref
Tammy Boggiano-Ayo, Julio Palacios-Oliva, Sumlai Lozada-Chang, Ernesto Relova-Hernandez, Jose Gomez-Perez, Gonzalo Oliva, Lourdes Hernandez, Alexi Bueno-Soler, Daidee Montes de Oca, Osvaldo Mora, Roberto Machado-Santisteban, Dayana Perez-Martinez, Beatriz Perez-Masson, Yanelys Cabrera Infante, Lisandra Calzadilla-Rosado, Yaima Ramirez, Judey Aymed-Garcia, Ingrid Ruiz-Ramirez, Yamile Romero, Tania Gomez, Luis A. Espinosa, Luis Javier Gonzalez, Annia Cabrales, Osmany Guirola, Kathya Rashida de la Luz, Franciscary Pi-Estopiñan, Belinda Sanchez-Ramirez, Dagmar Garcia-Rivera, Yuri Valdes-Balbin, Gertrudis Rojas, Kalet Leon-Monzon, Eduardo Ojito-Magaz & Eugenio Hardy. (2023) Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Germán Burgos, Andrés Ambuludí, Diana Morales-Jadán, Miguel Angel Garcia-Bereguiain, Claire Muslin, Vinicio Armijos-Jaramillo, Mateo Carvajal, Erika Muñoz, Rommel Guevara, Belén Prado, Sully Marquez, Josefina Coloma, Michelle Grunauer, Gabriel Trueba, Verónica Barragán, Patricio Rojas-Silva & Paúl Cárdenas. (2023) A tool for the cheap and rapid screening of SARS-CoV-2 variants of concern (VoCs) by Sanger sequencing. Microbiology Spectrum 11:5.
Crossref
Crossref
Jule L. Völzke, Sarah Smatty, Sarah Döring, Shireen Ewald, Marcus Oelze, Franziska Fratzke, Sabine Flemig, Zoltán Konthur & Michael G. Weller. (2023) Efficient Purification of Polyhistidine-Tagged Recombinant Proteins Using Functionalized Corundum Particles. BioTech 12:2, pages 31.
Crossref
Crossref
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang & Pengfei Wang. (2022) Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nature Reviews Immunology 23:3, pages 189-199.
Crossref
Crossref
Ehsan Raoufi, Fatemeh Hosseini, Bahman Onagh, Mohammad Salehi-Shadkami, Marjan Mehrali, Monireh Mohsenzadegan, Jim Q. Ho, Banafsheh Bigdelou, Mohammad Reza Sepand, Thomas J. Webster, Steven Zanganeh & Mohammad M. Farajollahi. (2023) Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples. Clinica Chimica Acta 542, pages 117279.
Crossref
Crossref
Anish Nag, Adhiraj Dasgupta, Sutirtha Sengupta, Tapan Kumar Lai & Krishnendu Acharya. (2023) An in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus. Computers in Biology and Medicine 152, pages 106433.
Crossref
Crossref
Theodore H. Tulchinsky, Elena A. Varavikova & Matan J. Cohen. 2023. The New Public Health. The New Public Health
215
366
.
Monu Yadav, Pratibha Dhakla, Rahul Rawat, Mini Dahiya & Anil Kumar. 2023. Drug Repurposing for Emerging Infectious Diseases and Cancer. Drug Repurposing for Emerging Infectious Diseases and Cancer
543
568
.
Aleksandra A. Mamchur, Tatiana B. Stanishneva-Konovalova, Yuliana A. Mokrushina, Viktoria A. Abrikosova, Yu Guo, Hongkai Zhang, Stanislav S. Terekhov, Ivan V. Smirnov & Igor A. Yaroshevich. (2022) Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein. Biomedicines 10:12, pages 3233.
Crossref
Crossref
DEVESH D GOSAVI & CHETA N SHINDE. (2022) COVID-19 VACCINES: TARGETS, PRE-CLINICAL STUDIES, MECHANISMS OF ACTION, ADRS, AND ROLLOUT IN INDIA – A JOURNEY SO FAR. Asian Journal of Pharmaceutical and Clinical Research, pages 24-30.
Crossref
Crossref
Juhyeon Kim, Saeyeon Cheon & Insung Ahn. (2022) NGS data vectorization, clustering, and finding key codons in SARS-CoV-2 variations. BMC Bioinformatics 23:1.
Crossref
Crossref
Yunxia He, Weili Yu, Lijuan Shen, Wenying Yan, Lucheng Xiao, Jinming Qi & Tao Hu. (2022) A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan. International Journal of Biological Macromolecules 222, pages 661-670.
Crossref
Crossref
María Victoria Díaz-Galián & Miguel A. Vega-Rodríguez. (2022) Many-objective approach based on problem-aware mutation operators for protein encoding. Information Sciences 613, pages 376-400.
Crossref
Crossref
Neil C. Dalvie, Christopher A. Naranjo, Sergio A. Rodriguez-Aponte, Ryan S. Johnston & J. Christopher Love. (2022) Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffii. Microbial Cell Factories 21:1.
Crossref
Crossref
Puneet Misra, Shashi Kant, Randeep Guleria, Sanjay K. Rai, Abhishek Jaiswal, Suprakash Mandal, Guruprasad R. Medigeshi, Mohammad Ahmad, Anisur Rahman, Meenu Sangral, Kapil Yadav, Mohan Bairwa, Partha Haldar & Parveen Kumar. (2022) Antibody Response to SARS-CoV-2 among COVID-19 Confirmed Cases and Correlates with Neutralizing Assay in a Subgroup of Patients in Delhi National Capital Region, India. Vaccines 10:8, pages 1312.
Crossref
Crossref
Fayaz Ali, Shahid Hussain & Yi Z. Zhu. (2022) A Therapeutic Journey of Potential Drugs Against COVID-19. Mini-Reviews in Medicinal Chemistry 22:14, pages 1876-1894.
Crossref
Crossref
Mohit Kumar, Raghav Dogra & Uttam Kumar Mandal. (2022) Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 74, pages 103533.
Crossref
Crossref
Xiaozhao Tang, Weili Yu, Lijuan Shen, Jinming Qi & Tao Hu. (2022) Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein. International Immunopharmacology 109, pages 108922.
Crossref
Crossref
Zhenzhen Wang, Kristen D. Popowski, Dashuai Zhu, Blanca López de Juan Abad, Xianyun Wang, Mengrui Liu, Halle Lutz, Nicole De Naeyer, C. Todd DeMarco, Thomas N. Denny, Phuong-Uyen C. Dinh, Zhenhua Li & Ke Cheng. (2022) Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nature Biomedical Engineering 6:7, pages 791-805.
Crossref
Crossref
Prashant Ranjan, Neha, Chandra Devi, Garima Jain, Chandana Basu Mallick & Parimal Das. (2022) Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach. Indian Journal of Medical Microbiology 40:3, pages 413-419.
Crossref
Crossref
Monikaben Padariya, Alison Daniels, Christine Tait-Burkard, Ted Hupp & Umesh Kalathiya. (2022) Self-derived peptides from the SARS-CoV-2 spike glycoprotein disrupting shaping and stability of the homotrimer unit. Biomedicine & Pharmacotherapy 151, pages 113190.
Crossref
Crossref
Alberto Rubio-Casillas, Elrashdy M. Redwan & Vladimir N. Uversky. (2022) SARS-CoV-2: A Master of Immune Evasion. Biomedicines 10:6, pages 1339.
Crossref
Crossref
Meng Zhang, Yixin Gong & Shunchang Jiao. (2022) Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent. Future Virology 17:6, pages 403-413.
Crossref
Crossref
Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Alireza Ranjbar, Mo Salman, Monireh Hajimoradi, Seyad Hossein Razaz, Maryam Taghdiri, Mohsen Bagheri, Maryam Dadar, Zuhair Mohammad Hassan, Mohammad Eslampanah, Zahra Salehi Najafabadi, Mohsen Lotfi, Akbar Khorasani & Fereidoon Rahmani. (2022) Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models. Frontiers in Immunology 13.
Crossref
Crossref
Ace Bryan Sotelo Cabal & Tzong-Yuan Wu. (2022) Recombinant Protein Technology in the Challenging Era of Coronaviruses. Processes 10:5, pages 946.
Crossref
Crossref
Eulhae Ga, Yongkwan Won, Jaehyun Hwang, Suyun Moon, Minju Yeom, Kwangsoo Lyoo, Daesub Song, Jeonghee Han & Woonsung Na. (2022) A COVID-19 Vaccine for Dogs Prevents Reverse Zoonosis. Vaccines 10:5, pages 676.
Crossref
Crossref
Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson, Paul R. Young, Mariusz Skwarczynski & Istvan Toth. (2022) Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics 14:4, pages 856.
Crossref
Crossref
Hong Zhou, Wei-Jian Ni, Wei Huang, Zhen Wang, Ming Cai & Yan-Cai Sun. (2022) Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19. Frontiers in Immunology 13.
Crossref
Crossref
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu & Vasso Apostolopoulos. (2022) A global picture: therapeutic perspectives for COVID-19. Immunotherapy 14:5, pages 351-371.
Crossref
Crossref
Qiong Long, Ying Yang, Mengli Yang, Hongmei Bai, Wenjia Sun, Xu Yang, Weiwei Huang, Duo Li & Yanbing Ma. (2022) Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response. Nanomedicine: Nanotechnology, Biology and Medicine 41, pages 102527.
Crossref
Crossref
Isabela A. Mattioli, Karla R. Castro, Lucyano J.A. Macedo, Graziela C. Sedenho, Mona N. Oliveira, Iris Todeschini, Phelipe M. Vitale, Suzete Cleusa Ferreira, Erika R. Manuli, Geovana M. Pereira, Ester C. Sabino & Frank N. Crespilho. (2022) Graphene-based hybrid electrical-electrochemical point-of-care device for serologic COVID-19 diagnosis. Biosensors and Bioelectronics 199, pages 113866.
Crossref
Crossref
Neil C. Dalvie, Andrew M. Biedermann, Sergio A. Rodriguez‐Aponte, Christopher A. Naranjo, Harish D. Rao, Meghraj P. Rajurkar, Rakesh R. Lothe, Umesh S. Shaligram, Ryan S. Johnston, Laura E. Crowell, Seraphin Castelino, Mary K. Tracey, Charles A. Whittaker & J. Christopher Love. (2021)
Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered
Komagataella phaffii
. Biotechnology and Bioengineering 119:2, pages 657-662.
Crossref
Crossref
Surendra S. Negi, Catherine H. Schein & Werner Braun. (2022) Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis. Scientific Reports 12:1.
Crossref
Crossref
Iuliia A. Merkuleva, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Daniil V. Shanshin, Andrey P. Rudometov, Larisa I. Karpenko, Svetlana V. Belenkaya, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Elena I. Kazachinskaia, Ekaterina A. Volosnikova, Tatiana I. Esina, Anna V. Zaykovskaya, Oleg V. Pyankov, Sophia S. Borisevich, Arseniya A. Shelemba, Anton N. Chikaev & Alexander A. Ilyichev. (2022) Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems. Vaccines 10:1, pages 96.
Crossref
Crossref
Sukrit Srivastava, Spyros D. Chatziefthymiou & Michael Kolbe. 2022. Vaccine Design. Vaccine Design
149
175
.
Hossam M. Zawbaa, Hasnaa Osama, Ahmed El‐Gendy, Haitham Saeed, Hadeer S. Harb, Yasmin M. Madney, Mona Abdelrahman, Marwa Mohsen, Ahmed M. A. Ali, Mina Nicola, Marwa O. Elgendy, Ihab A. Ibrahim & Mohamed E. A. Abdelrahim. (2021) Effect of mutation and vaccination on spread, severity, and mortality of COVID‐19 disease. Journal of Medical Virology 94:1, pages 197-204.
Crossref
Crossref
Neil C. Dalvie, Sergio A. Rodriguez-AponteBrittany L. HartwellLisa H. Tostanoski, Andrew M. BiedermannLaura E. CrowellKawaljit KaurOzan S. KumruLauren CarterJingyou YuAiquan Chang, Katherine McMahanThomas CourantCelia LebasAshley A. Lemnios, Kristen A. Rodrigues, Murillo SilvaRyan S. JohnstonChristopher A. NaranjoMary Kate TraceyJoseph R. Brady, Charles A. Whittaker, Dongsoo YunNatalie BrunetteJing Yang Wang, Carl WalkeyBrooke Fiala, Swagata KarMaciel PortoMegan LokHanne AndersenMark G. Lewis, Kerry R. LoveDanielle L. CampJudith Maxwell SilvermanHarry KleanthousSangeeta B. JoshiDavid B. VolkinPatrice M. Dubois, Nicolas CollinNeil P. KingDan H. BarouchDarrell J. Irvine & J. Christopher Love. (2021) Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice. Proceedings of the National Academy of Sciences 118:38.
Crossref
Crossref
Hassan Dariushnejad, Vajihe Ghorbanzadeh, Soheila Akbari & Pejman Hashemzadeh. (2021) Designing a Multi-epitope Peptide Vaccine Against COVID-19 Variants Utilizing In-silico Tools. Iranian Journal of Medical Microbiology 15:5, pages 592-605.
Crossref
Crossref
Yuying Lu, Jin Wang, Qianlin Li, Huan Hu, Jiahai Lu & Zeliang Chen. (2021) Advances in Neutralization Assays for SARS‐CoV‐2. Scandinavian Journal of Immunology 94:3.
Crossref
Crossref
Francesca Levi‐Schaffer & Ario de Marco. (2021) Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31. British Journal of Pharmacology 178:17, pages 3359-3372.
Crossref
Crossref
Xianghui Li, Zhiqiang Zhang, Zhenhuan Guo, Xia Ma, Xueting Ban, Xinghui Song, Yonglu Liu, Li Zhao, Qiqi Liu & Qigai He. (2021) Acanthopanax senticosus polysaccharide-loaded calcium carbonate nanoparticle as an adjuvant to enhance porcine parvovirus vaccine immune responses. Medicine in Drug Discovery 11, pages 100094.
Crossref
Crossref
Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, Zia Ur Rahman & Zainab Fatima. (2021) Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development. Exploration of Immunology.
Crossref
Crossref
Salomé de Sá Magalhães & Eli Keshavarz-Moore. (2021) Pichia pastoris (Komagataella phaffii) as a Cost-Effective Tool for Vaccine Production for Low- and Middle-Income Countries (LMICs). Bioengineering 8:9, pages 119.
Crossref
Crossref
Ryan Taoran Wang, Alex Fan Xu, Qi Zhou, Tinglu Song, Kelvin J. Xu & Gu Xu. (2021) Binding Strength and Hydrogen Bond Numbers between COVID-19 RBD and HVR of Antibody. Crystals 11:8, pages 997.
Crossref
Crossref
Leon G Leanse, Carolina dos Anjos, João Felipe Besegato, Tianhong Dai & Alessandra N S Rastelli. (2021) Shedding UVC light on Covid-19 to protect dentistry staff and patients. Laser Physics Letters 18:8, pages 085602.
Crossref
Crossref
Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczynski & Istvan Toth. (2021) Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative. Advanced Science 8:16.
Crossref
Crossref
Daniel W. Binzel, Xin Li, Nicolas Burns, Eshan Khan, Wen-Jui Lee, Li-Ching Chen, Satheesh Ellipilli, Wayne Miles, Yuan Soon Ho & Peixuan Guo. (2021) Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine—Specific Cancer Targeting with Undetectable Toxicity. Chemical Reviews 121:13, pages 7398-7467.
Crossref
Crossref
Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flavia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid J. Alzahrani, Aristóteles Góes-Neto, Marianna E. Weener, Preetam Ghosh & Vasco Azevedo. (2021) The Spike of SARS-CoV-2: Uniqueness and Applications. Frontiers in Immunology 12.
Crossref
Crossref
В.Г. Спиридонов & М.Д. Мельничук. (2021) Коронавірусний S-антиген як маркер ефективної вакцинації. Reports of the National Academy of Sciences of Ukraine:3, pages 96-103.
Crossref
Crossref
Lili Li, Meiling Gao, Jie Li, Shulong Zu, Yanan Wang, Chunfeng Chen, Dingyi Wan, Jing Duan, Roghiyh Aliyari, Jingfeng Wang, Jicai Zhang, Yujie Jin, Weijin Huang, Xiaoxia Jin, Minxin Shi, Youchun Wang, Cheng‐Feng Qin, Heng Yang & Genhong Cheng. (2021) Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients. Small Methods 5:7.
Crossref
Crossref
Samuel L Whittle, Glen S Hazlewood, Philip Robinson, Renea V Johnston, Karin Leder, Vanessa Glennon, Jodie C Avery, Liesl Grobler & Rachelle Buchbinder. (2021) COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Crossref
Delyan Hristov, Hom Rijal, Jose Gomez-Marquez & Kimberly Hamad-Schifferli. (2021) Developing a Paper-Based Antigen Assay to Differentiate between Coronaviruses and SARS-CoV-2 Spike Variants. Analytical Chemistry 93:22, pages 7825-7832.
Crossref
Crossref
Wen-Hsiang Chen, Junfei Wei, Rakhi Tyagi Kundu, Rakesh Adhikari, Zhuyun Liu, Jungsoon Lee, Leroy Versteeg, Cristina Poveda, Brian Keegan, Maria Jose Villar, Ana C. de Araujo Leao, Joanne Altieri Rivera, Portia M. Gillespie, Jeroen Pollet, Ulrich Strych, Bin Zhan, Peter J. Hotez & Maria Elena Bottazzi. (2021) Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:6, pages 129893.
Crossref
Crossref
Yunxia He, Jinming Qi, Lucheng Xiao, Lijuan Shen, Weili Yu & Tao Hu. (2021)
Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from
Escherichia coli
. Engineering in Life Sciences 21:6, pages 453-460.
Crossref
Crossref
Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Seyed Dawood Mousavi Nasab, Farzin Roohvand & Zabihollah Shoja. (2020) Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects. Reviews in Medical Virology 31:3.
Crossref
Crossref
Long Min & Qiu Sun. (2021) Antibodies and Vaccines Target RBD of SARS-CoV-2. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Gajanan Sampatrao Ghodake, Surendra Krushna Shinde, Avinash Ashok Kadam, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Asad Syed, Abdallah M. Elgorban, Najat Marraiki & Dae-Young Kim. (2021) Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures. Biosensors and Bioelectronics 177, pages 112969.
Crossref
Crossref
Taruna Anand, Nitin Virmani, Bidhan C. Bera, Rajesh K. Vaid, Medhavi Vashisth, Priyanka Bardajatya, Ashok Kumar & Bhupendra N. Tripathi. (2021) Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses. Current Microbiology 78:4, pages 1124-1134.
Crossref
Crossref
Mohau S. Makatsa, Marius B. Tincho, Jerome M. Wendoh, Sherazaan D. Ismail, Rofhiwa Nesamari, Francisco Pera, Scott de Beer, Anura David, Sarika Jugwanth, Maemu P. Gededzha, Nakampe Mampeule, Ian Sanne, Wendy Stevens, Lesley Scott, Jonathan Blackburn, Elizabeth S. Mayne, Roanne S. Keeton & Wendy A. Burgers. (2021) SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients. Frontiers in Plant Science 12.
Crossref
Crossref
Mijia Lu, Piyush Dravid, Yuexiu ZhangSheetal TrivediAnzhong LiOlivia HarderMahesh KC, Supranee Chaiwatpongsakorn, Ashley ZaniAdam KenneyCong ZengChuanxi Cai, Chengjin YeXueya LiangMasako ShimamuraShan-Lu LiuAsuncion MejiasOctavio RamiloProsper N. Boyaka, Jianming Qiu, Luis Martinez-SobridoJacob S. YountMark E. PeeplesAmit KapoorStefan NiewieskJianrong Li. (2021) A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Proceedings of the National Academy of Sciences 118:12.
Crossref
Crossref
Jiao Tong, Chenxi Zhu, Hanyu Lai, Chunchao Feng & Dapeng Zhou. (2021) Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19. Vaccines 9:3, pages 296.
Crossref
Crossref
Timothy Cardozo & Ronald Veazey. (2020) Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease. International Journal of Clinical Practice 75:3.
Crossref
Crossref
Calvin P. Sjaarda, Nazneen Rustom, Gerald A. Evans, David Huang, Santiago Perez-Patrigeon, Melissa L. Hudson, Henry Wong, Zhengxin Sun, T. Hugh Guan, Muhammad Ayub, Claudio N. Soares, Robert I. Colautti & Prameet M. Sheth. (2021) Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada. Scientific Reports 11:1.
Crossref
Crossref
Puneet K. Samaiya & Mahendra Kumar. (2021) SARS-CoV-2 Therapy: Old Drugs as New Interventions. Coronaviruses 2:2, pages 142-150.
Crossref
Crossref
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, Shaogeng Tang, Payton A. Weidenbacher, Shanshan Li, Tho D. Pham, John E. Pak, Wah Chiu & Peter S. Kim. (2021) A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice. ACS Central Science 7:1, pages 183-199.
Crossref
Crossref
Jarek Juraszek, Lucy Rutten, Sven Blokland, Pascale Bouchier, Richard Voorzaat, Tina Ritschel, Mark J. G. Bakkers, Ludovic L. R. Renault & Johannes P. M. Langedijk. (2021) Stabilizing the closed SARS-CoV-2 spike trimer. Nature Communications 12:1.
Crossref
Crossref
Salvatore Dimonte, Muhammed Babakir-Mina, Taib Hama-Soor & Salar Ali. (2021) Genetic Variation and Evolution of the 2019 Novel Coronavirus. Public Health Genomics 24:1-2, pages 54-66.
Crossref
Crossref
Malik Sallam, Nidaa A. Ababneh, Deema Dababseh, Faris G. Bakri & Azmi Mahafzah. (2021) Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa. Heliyon 7:1, pages e06035.
Crossref
Crossref
Shirin Moossavi, Kelsey Fehr, Hassan Maleki, Simin Seyedpour, Mahdis Keshavarz-Fathi, Farhad Tabasi, Mehrdad Heravi, Rayka Sharifian, Golnaz Shafiei, Negin Badihian, Roya Kelishadi, Shahrzad Nematollahi, Majid Almasi, Saskia Popescu, Mahsa Keshavarz-Fathi & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19
575
604
.
Chiara Lico, Luca Santi, Selene Baschieri, Emanuela Noris, Carla Marusic, Marcello Donini, Emanuela Pedrazzini, Giovanni Maga, Rosella Franconi, Paola Di Bonito & Linda Avesani. (2020) Plant Molecular Farming as a Strategy Against COVID-19 – The Italian Perspective. Frontiers in Plant Science 11.
Crossref
Crossref
Ambrish Saxena. (2020) Drug targets for COVID-19 therapeutics: Ongoing global efforts. Journal of Biosciences 45:1.
Crossref
Crossref
Mohammad Oves, Mithunan Ravindran, Mohd Ahmar Rauf, Mohammad Omaish Ansari, Maryam Zahin, Arun K. Iyer, Iqbal M. I. Ismail, Meraj A. Khan & Nades Palaniyar. (2020) Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development. Pathogens 9:12, pages 985.
Crossref
Crossref
Swati Jain, Himanshu Batra, Poonam Yadav & Subhash Chand. (2020) COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response. Vaccines 8:4, pages 649.
Crossref
Crossref
Ya. M. Krasnov, A. Yu. Popova, V. A. Safronov, A. V. Fedorov, D. V. Badanin, S. A. Shcherbakova & V. V. Kutyrev. (2020) Genomic Diversity Analysis of SARS-CoV-2 and Epidemiological Features of Adaptation of COVID-19 Agent to Human Population (Communication 1). Problems of Particularly Dangerous Infections:3, pages 70-82.
Crossref
Crossref
Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, Ran Tao, Xiaoqin Wang, Yinfeng Shen, Lihan Xie, Yuanming Ba, Hezhen Wu & YanFang Yang. (2020) “Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study. Frontiers in Pharmacology 11.
Crossref
Crossref
Kenneth Lundstrom. (2020) The Current Status of COVID-19 Vaccines. Frontiers in Genome Editing 2.
Crossref
Crossref
Jaison Jeevanandam, Subhamoy Banerjee & Rajkumar Paul. (2020) Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome- Corona Virus 2 (SARS-COV-2). Journal of Biomedical Research & Environmental Sciences 6:10, pages 219-232.
Crossref
Crossref
Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Muhammad E.H. Chowdhury, Majid Sharifi, Setareh Haghighat & Mojtaba Falahati. (2020) Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies. Biomedicine & Pharmacotherapy 130, pages 110559.
Crossref
Crossref
Puja Adhikari, Neng Li, Matthew Shin, Nicole F. Steinmetz, Reidun Twarock, Rudolf Podgornik & Wai-Yim Ching. (2020) Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding. Physical Chemistry Chemical Physics 22:33, pages 18272-18283.
Crossref
Crossref
John P. Moore & P. J. Klasse. (2020) COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds. Journal of Virology 94:17.
Crossref
Crossref
Bette Korber, Will M. Fischer, Sandrasegaram Gnanakaran, Hyejin Yoon, James Theiler, Werner Abfalterer, Nick Hengartner, Elena E. Giorgi, Tanmoy Bhattacharya, Brian Foley, Kathryn M. Hastie, Matthew D. Parker, David G. Partridge, Cariad M. Evans, Timothy M. Freeman, Thushan I. de Silva, Charlene McDanal, Lautaro G. Perez, Haili Tang, Alex Moon-Walker, Sean P. Whelan, Celia C. LaBranche, Erica O. Saphire, David C. Montefiori, Adrienne Angyal, Rebecca L. Brown, Laura Carrilero, Luke R. Green, Danielle C. Groves, Katie J. Johnson, Alexander J. Keeley, Benjamin B. Lindsey, Paul J. Parsons, Mohammad Raza, Sarah Rowland-Jones, Nikki Smith, Rachel M. Tucker, Dennis Wang & Matthew D. Wyles. (2020) Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell 182:4, pages 812-827.e19.
Crossref
Crossref
Rasoul Mirzaei, Sajad Karampoor, Mohammad Sholeh, Pouya Moradi, Reza Ranjbar & Faezeh Ghasemi. (2020) A contemporary review on pathogenesis and immunity of COVID-19 infection. Molecular Biology Reports 47:7, pages 5365-5376.
Crossref
Crossref
Nikoo Hossein-khannazer, Bahare Shokoohian, Anastasia Shpichka, Hamid Asadzadeh Aghdaei, Peter Timashev & Massoud Vosough. (2020) Novel therapeutic approaches for treatment of COVID-19. Journal of Molecular Medicine 98:6, pages 789-803.
Crossref
Crossref
Marzia Nuccetelli, Massimo Pieri, Sandro Grelli, Marco Ciotti, Roberto Miano, Massimo Andreoni & Sergio Bernardini. (2020) SARS-CoV-2 infection serology: a useful tool to overcome lockdown?. Cell Death Discovery 6:1.
Crossref
Crossref